Non-occlusive mesenteric ischemia and the role of cilostazol in its management
K. A. Sudharshana Murthy1, H. S. Kiran1, Vijay Cheluvaraj1, Abhijit Bhograj1★★ Corresponding author
- 1Department of Medicine, JSS Medical College and Hospital, Mysore Constituent College of JSS University, (Deemed University), Karnataka, India.
CORRESPONDENCE
Abhijit Bhograj
Department of Medicine, JSS Medical College and Hospital, Mysore Constituent College of JSS University, (Deemed University), Karnataka, India.
Volume 3, Issue 1 · pp. 68–70 · PUBLISHED 2012 · DOI: 10.4103/0976-500X.92513
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Bowel ischemia is a rare and potential life-threatening disorder. The reason for its rarity is the difficulty in its diagnosis. Vague and nonspecific clinical findings and limitations of diagnostic and treatment options make this disease a significant challenge. We hereby report two cases of non-occlusive mesenteric ischemia and the use of cilostazol in the successful management of such cases.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Murthy, K. A. S., Kiran, H. S., Cheluvaraj, V., & Bhograj, A. (2012). Non-occlusive mesenteric ischemia and the role of cilostazol in its management. Journal of Pharmacology and Pharmacotherapeutics, 3(1), 68–70. https://doi.org/10.4103/0976-500X.92513